_256_384.jpg)
News | September 18, 2021
India extends concession on life-saving Covid-19 drugs till December 2021
The council has also reduced the GST to 5 per cent on a few more Covid-19 medicines
The council has also reduced the GST to 5 per cent on a few more Covid-19 medicines
Union Minister addresses the 13th CII Global MedTech Summit on the sunrise medical devices sector in India
The govt has rolled out three schemes for promoting the manufacture of API
NATCO Pharmaceuticals, Hyderabad; Alembic Pharmaceuticals, Vadodara; Gufic Biosciences Ltd., Gujarat; Emcure Pharmaceuticals, Pune; and Lyka, Gujarat are new manufacturers
The additional allocation of Tocilizumab will ensure sufficient availability for COVID-19 patients and augment the government’s efforts to fight the pandemic
State governments and UTs have been asked to monitor proper distribution within the state/UT covering government and private hospitals
The Department of Pharmaceuticals launched the PLI scheme for promoting domestic manufacturing of bulk drugs, with a financial outlay of Rs. 6,940 crore across 53 APIs over 6 years
Indian government is expecting pharmaceutical industry to fetch incremental sales worth Rs. 294,000 crore and exports up to Rs. 196,000 crore by FY 2027-28
The government has taken all the effective measures to make healthcare affordable
Integration of various regulatory agencies with a single-window system and putting in place a transparent, stable, predictable and easy to navigate interface.
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)